ReviewDiabetes & vascular disease research

Patient-important outcomes in type 2 diabetes: The paradigm of the sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists.

Kyriakos Kintzoglanakis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.